COVID-19/Influenza(A+B)/RSV Antigen Combo Rapid Test Kit(Colloidal gold method)
by Synthgene (Yixing) Health Technology Co., Ltd.
Ref RQ009
Active
CE IVDD
Valid until
Not listed
FDA recalls
Not applicable
Documents
None, self-declared
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD | NumberB-CNMF000054349RQ009MK D-CNMF000054349RQ009MK | Date12 May 2026 | StatusActive |
Certificates
No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/IVDD Active
Specification
- Model / Reference
- RQ009
- Primary DI / UDI-DI
- D-CNMF000054349RQ009MK
- Basic UDI-DI
- B-CNMF000054349RQ009MK
- EMDN Code
- W0105070399 Multiple viruses - multiplex assays - other
- Device Class
- Class IVD General
- EU market of registration
- Germany
Manufacturer details
- EUDAMED SRN
- CN-MF-000054349
- Authorised representative
- MedPath GmbH DE-AR-000000087
Other devices from Synthgene (Yixing) Health Technology Co., Ltd.
See all devices from Synthgene (Yixing) Health Technology Co., Ltd. →
Properties
Other properties (7)
- Sterile: No
- Human Tissues: No
- Microbial Substances: No
- Self Testing: No
- Near-Patient Testing: No
- Companion Diagnostics: No
- Surgical Instrument: No